Why the study?
Does reteplase improve 1-year survival compared to alteplase in patients with acute myocardial infarction?
Population
15,059 patients with acute myocardial infarction enrolled in the GUSTO-III trial
Comparison
Reteplase (r-PA) vs Alteplase (t-PA)
Design
RCT, random assignment
Follow-up
1 year
Authors
Loading...
Either agent is acceptable for AMI thrombolysis; confirms 1-year equivalence between reteplase and alteplase.
Does reteplase improve 1-year survival compared to alteplase in patients with acute myocardial infarction?
Reteplase and alteplase yielded similar 1-year survival outcomes in patients with acute myocardial infarction.
Topol et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: